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Abstract
Perinatal infection of cytomegalovirus (CMV) may cause cholestasis resembling biliary atresia. CMV 
infection is found in patients with biliary atresia. This simultaneous occurrence of biliary atresia and CMV 
infection prompted speculation that CMV may contribute to the progression of biliary atresia. This report has 
the objective to obtain the evidence regarding the association between biliary atresia and CMV infection. 
Two databases were searched to obtain the evidence: PubMed and Scopus. The study design which was 
selected for this report was case control due to its relevance to answer the clinical question. There were two 
case control studies which are appropriate to answer the clinical question.  Both studies showed that biliary 
atresia is associated with CMV infection (OR>1). Biliary atresia is associated with CMV infection at the time of 
diagnosis, therefore the presence of CMV infection in neonatal cholestasis should not delay the investigation 
towards biliary atresia.
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Hubungan Atresia Bilier dan Infeksi Sitomegalovirus
Abstrak
Infeksi sitomegalovirus perinatal dapat menyebabkan kolestasis yang menyerupai atresia bilier. 
Infeksi tersebut juga ditemukan pada pasien dengan atresia bilier. Kejadian atresia bilier dengan infeksi 
sitomegalovirus menimbulkan dugaan bahwa sitomegalovirus berperan pada terjadinya atresia bilier. Laporan 
kasus berbasis bukti ini bertujuan menyajikan bukti hubungan atresia bilier dengan infeksi sitomegalovirus. 
Laporan ini menggunakan dua basis data dalam pengumpulan bukti, yakni PubMed dan Scopus. Disain 
penelitian yang relevan untuk menjawab pertanyaan kilinis pada kasus ini adalah case-control. Dua penelitian 
yang disajikan menunjukkan bahwa atresia biliar berhubungan dengan infeksi sitomegalobirus (OR>1). Oleh 
karena itu, didapatkannya  infeksi sitomegalovirus pada kolestasis neonatus tidak boleh menunda penelusuran 
diagnosis ke arah atresia bilier.
Kata kunci: atresia bilier; infeksi cytomegalovirus; serologi.
Meutia Ayuputeri, et al
128
eJKI
Introduction
Cholestasis is defined as reduced bile flow 
and abnormal accumulation of conjugated bilirubin, 
indicating impaired hepatobiliary function. Obstructive 
(extrahepatic, intrahepatic) or hepatocellular (infectious, 
metabolic, toxic, genetic or idiopathic) diseases 
may cause cholestasis in newborns and infants.1 
Extrahepatic biliary atresia, subsequently mentioned 
as biliary atresia, was reported to occur in 1 in 
18.000-20.000 live births, more commonly in Asians 
(1 in 5.000-8.000).2 The role of infectious agents in 
causing postnatal bile duct obstruction has been 
heavily suggested but remains controversial and 
inconclusive. Although cytomegalovirus (CMV) is 
known to cause intrahepatic bile duct destruction and 
paucity, its role as the cause of EHBA has been a 
topic of much debate.3
CMV is a double-stranded DNA virus of the 
Herpesviridae family that infects biliary epithelia, as 
demonstrated by CMV inclusion bodies within the 
epithelia. CMV infection is present in 1-2.4% North 
American newborns, possibly higher in developing 
country like Indonesia. Congenital CMV infection 
ranges from 0.2-2.2% of all live births and perinatal 
transmission is even more common (10-60% in the 
first 6 months of life). 
The perinatal infection of CMV is commonly 
through genital secretion of the mother and breastmilk. 
Perinatal infections of CMV are usually asymptomatic, 
but can cause cholestasis resembling biliary atresia.4 
Furthermore, CMV infection is also found in patients 
with biliary atresia. This simultaneous occurrence of 
biliary atresia and CMV infection prompted speculation 
that CMV may contribute to the progression of biliary 
atresia.5,6 However, in some cases, CMV infection in 
neonates may postpone investigation towards biliary 
atresia. A study by Tarr et al5 demonstrated that biliary 
atresia patients with ongoing CMV infection were 
referred later than non-infected patients.
Biliary atresia, manifested by progressive 
inflammation and fibrosis of extra-hepatic and 
intrahepatic bile ducts, is the major cause of neonatal 
cholestasis in Dr. Cipto Mangunkusumo National 
Hospital, Jakarta, accounting for 23% cases from 
2000-2003.7 It is a devastating disease that leads 
to cirrhosis and the need for liver transplantation in 
the majority of children.8 The etiology is unknown, 
and one proposed theory is that it may involve a 
primary perinatal hepatobiliary viral infection and a 
secondary generation of an autoimmune-mediated 
bile duct injury.4
Case Illustration
The patient was a baby girl aged 13 months 
old and was hospitalized with jaundice, pneumonia, 
GI bleeding and ascites. She was born through a 
caesarian section at term and weighed 3.600 g 
and measured 49.5 cm. She was presented with 
jaundice from the age of one week. At the age of 
three months, her direct bilirubin level was 3 mg/dL 
and she was tested positive with CMV infection at 
that time and was given anti-cholestatic treatment 
of ursodeoxycholic acid.  She was diagnosed with 
biliary atresia. According to the mother, she did not 
receive any surgical procedure according to the 
infection. A liver transplantation was planned for 
her once her condition improved.
Clinical Question
Is there any association between CMV infection 
and biliary atresia?
Methods
This is an etiologic question, therefore cohort 
study and case control study are the suitable study 
design to find the answer to our clinical question. 
Biliary atresia is a rare disease, therefore case 
control study is the type of study to be used. Two 
databases namely Pubmed and Scopus were used 
to search relevant studies for our clinical question. 
The search was done on 7 September 2013 and 
was limited to articles published from 2000-2013. 
All articles were evaluated for suitability according 
to pre-defined inclusion and exclusion criteria. 
Biliary atresia, CMV, and etiology were used as 
keywords. 
Results
The search yielded two cross sectional studies 
from the last 13 years. However, these cross 
sectional results are not satisfactory to answer 
our clinical question. Subsequent hand-search 
was done that resulted in one case-control study 
dated back to 1998. The details of the search are 
illustrated in Figure 1. 
Critical appraisal utilises appraisal tools from 
the Center of EBM, University of Oxford for etiology 
and case control studies. Validity of the study is 
shown in table 1.
 The Association Between Biliary Atresia
129
Vol. 5, No. 2, Agustus 2017
Figure 1. Flow Chart Depicting Retrieval of The Results from The Two Databases and Hand-search
Table 1. Validity of The Study
Validity Fischler
et al9
Zabiegaj-Zwick  
et al2
Were there clearly defined groups of patients, similar in all important 
ways other than exposure to the treatment or other cause?
Were treatment exposures and clinical outcomes measured the same 
ways in both groups (e.g. was the assessment of outcomes either 
objective or blinded to exposure?)
Was the follow-up study patients complete and long enough? NA NA
Do the results satisfy some “diagnostic tests for causation”?
- Is it clear that the exposure preceded the onset of outcome?
- Is there a dose-response gradient?
- Is there positive evidence from a “dechallenge-rechallenge” study?
- Is the association consistent from study to study?
- Does the association make biological sense?
Are the results of this harm study valid?
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The importance of this study was measured by 
using serology IgM as surrogate of CMV infection 
and biliary atresia as the outcome. The odds ratio 
(OR) for biliary atresia  was 10.15 (95%CI: 7.63-
12.68, p<005).
The study by Fischleret al9 also included liver 
biopsy from some of the cases and some of the 
controls. A subsequent PCR was done to detect 
the presence of local and ongoing CMV infection in 
the liver and hepatobiliary tree. This made a better 
surrogate to the measurement of importance. The 
odds ratio of 1.33 signified the importance of the 
effect in this study. Infants with CMV infection was 
33% more likely to develop biliary atresia than non-
infected infants.
The odds ratio signified 10-fold increase risk 
in developing biliary atresia in infants with CMV 
infection. Both of the studies can be extrapolated 
to our patient. The patient’s risk of developing 
biliary atresia by CMV infection (number needed to 
harm, NNH) was 11.23 (95% CI: 11 to 12, for IgM 
measurement) in Fischler et al9 study and 11 (95% 
CI: 11 to 12) in Zabiegaj-Zwick et al2 study.
Table 2. Comparison between Study and Patient Characteristics
Fischler et al9 Zabiegaj-Zwick et al2 Our patient 
Entry Jaundice (neonatal 
cholestasis)
Jaundice (neonatal 
cholestasis)
Jaundice
Age at diagnosis of biliary 
atresia  
8 weeks 
(1-21 weeks)
Not mention 12 weeks
Methods of detection 
of CMV infection
Serology IgM
Liver biopsy
Serology IgM/IgG Blood test?
Place of treatment Tertiary referral centre Referral Hospital Tertiary referral centre
Ethnicity Caucasian ? Possibly African Asian
Table 3. The Review of the Study According to Oxford Centre for EBM 2011 Levels of Evidence11
Author Study Design
Target 
Population 
(n)
Study Criteria Indicators (Outcome)
Outcome 
Measures  
(Follow-up 
Duration)
Missing Data
Level of 
Evidence*Drop 
Out (%)
Loss to 
Follow-
up (%)
Fischler 
et al9 
(1998)
Case 
control
21 (cases)
35 control)
Inclusion criteria:
- Infants with neonatal 
cholestasis at 
Sweden tertiary 
referral center 
between July 
1988-February 1995
- Jaundiced 
Exclusion criteria:
- Infants with other 
hepatotropic viral 
infection
Biliary 
atresia NA NA NA 4
Zabiegaj-
Zwick 
et al2
(2012)
Case 
Control
27 (cases)
31 (control)
Inclusion criteria:
- Cholestatic 
jaundiced referred to 
Paediatric Surgical 
Unit, Tygerberg
- Serologic test of 
CMV
Exclusion criteria
- Other infection
B i l i a r y 
atresia NA NA NA 4
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Looking at our patient restrospectively, these 
two studies are highly applicable due to the 
similarities of characteristics mentioned above 
(Table 2). The presence of CMV infection and 
neonatal cholestasis in primary care setting (in 
the absence of other common etiology of neonatal 
cholestasis) should prompt to suspicion towards 
biliary atresia to allow prompt management of 
biliary atresia.
Discussion
Fischler et al9 conducted a case-control study to 
investigate the association between CMV infection 
and biliary atresia. The study demonstrated that the 
OR of biliary atresia were 33% higher in patient with 
CMV infection detected through liver. This OR was 
statistically significant because the 95% confidence 
interval (CI) of this estimate (95% CI: 1.07-1.59) did 
not include 1.
Subsequent study was done by the same 
group in 2005 analysing liver biopsy from 18 biliary 
atresia patients and 6 control patients without 
liver disease. The study showed higher serum 
CMV-IgM levels in infants with biliary atresia and 
greater amounts of immunoglobulin deposits on the 
canalicular membrane of the hepatocytes in infants 
with biliary atresia with ongoing CMV infection. This 
finding suggests the possibility that immunologic 
mechanisms are of importance in the pathogenesis 
of biliary atresia and that a CMV infection may 
trigger such mechanisms.10
The studies by Fischler et al9 and Zabiegaj-
Zwick et al2 were limited by a small sample size and 
larger studies may be needed to detect a difference. 
In addition, the nature of this study (case control) 
prevents determination of the exact timing of CMV 
infection in subjects. It would be interesting to see 
future case control studies in this area especially 
considering subsequent studies (1998-now) are 
mostly cross sectional in design.
The study by Zabiegaj-Zwick et al2 which tried 
to observe the correlation between CMV exposure/
infection and biliary atresia affected the clinical outcome 
(OR: 10.06, 95% CI: 7.60 to 12.52). In developing 
countries like South Africa, CMV seropositivity (IgG) 
was high (up to 90%). On top of that, The South African 
population has a high background CMV infection rate in 
pregnant women. Therefore, in this context, it is difficult 
to determine when CMV infection is the unequivocal 
cause of biliary atresia.
Another principal difficulty in making the 
connection between CMV infection and biliary 
atresia is that no single test is 100% sensitive 
and/or specific for CMV infection. Differences in 
sampling and diagnosis method may account for 
variations and conflicting results in existing studies.
Proposed Mechanism of Bile Duct Injury Due to 
Hepatotrophic Virus
One could postulate that if the newborn was 
exposed to low levels of virus in the perinatal period, 
the neonatal immune system could elicit a Th1 
cellular response with production of virus-specific 
memory T cells that, upon re-stimulation with virus 
would become activated and secrete Th1 cytokines 
(IFN-γ). Brindley et al12 analyzed the liver memory T 
cell response to a variety of viruses from infants with 
newly diagnosed biliary atresia in order to ascertain 
if a recent hepatobiliary virus infection had occurred. 
Liver T cells from biliary atresia and control 
patients were cultured with antigen presenting 
cells in the presence of a variety of viral proteins 
including CMV, Epstein-Barr virus, reovirus and 
rotavirus. Fifty-six percent of biliary atresia patients 
had significant increases in IFN-γ-producing liver T 
cells in response to CMV homogenate and CMV-
pp65 antigen, compared to minimal/no biliary atresia 
responses to other viruses or the control group CMV 
response. The robust liver T cell memory response 
to CMV suggested that perinatal CMV infection had 
occurred and that CMV infection was a plausible 
initiator of the bile duct damage in biliary atresia.13
Another possible explanation is that innate 
immune response in biliary atresia at diagnosis 
is similar to that seen with viral infections. Virus 
infection of bile duct epithelia activates TLRs on 
dendritic cells, macrophages and bile duct epithelia, 
leading to upregulation of MxA transcription factor 
and downstream stimulation of type 1 interferons 
(IFN). Concurrently, macrophages are activated, 
with increased expression of CD14 and production 
of pro-inflammatory cytokines. Both type 1 IFNs 
and inflammatory cytokines play a direct role in bile 
duct epithelial injury and apoptosis. It is theorized 
that a sustained induction of the innate response, 
without the development of tolerance, could explain 
the chronic inflammation and bile duct destruction 
found in biliary atresia.13
Conclusion
CMV infection is associated with biliary atresia 
in neonates and infants at the time of diagnosis. 
CMV infection is postulated to mediate immune 
response to cause damage to the structure of liver 
and biliary tree, causing biliary atresia. Although 
most CMV infection in infants and neonates are 
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asymptomatic, the establishment of CMV infection 
should not deter nor delay the investigation for 
biliary atresia, as it needs prompt intervention.
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